1. Market Research
  2. > Healthcare Market Trends
Autotransfusion Devices Market Forecast to 2028- COVID-19 Impact and Global Analysis - by Type ; Application ; End User

Autotransfusion Devices Market Forecast to 2028- COVID-19 Impact and Global Analysis - by Type ; Application ; End User

  • March 2022
  • 178 pages
  • ID: 6269980
  • Format: PDF
  • The Insight Partners

Summary

Table of Contents

Search Inside

The autotransfusion devices market is expected to grow from US$ 1,000.26 million in 2021 to US$ 1,331.99 million by 2028; it is estimated to grow at a CAGR of 4.2% from 2021 to 2028.

Rapid increase in chronic diseases, rise in transplants, and difficulty in obtaining blood groups across the globe are driving the growth of the market. However, the product recalls and Risks Associated with Autotransfusion are hamper the autotransfusion devices market growth.

The outbreak of COVID-19 pandemic had a negative impact on autotransfusion devices market growth.It showcased a huge decline in revenue due to stringent restrictions imposed by the government resulting in decreasing number of surgical procedures performed.

The devices are mainly used in surgeries with high blood loss such as orthopaedic and cardiac surgeries.Due to decreasing number of surgeries performed, the demand for autologous blood transfusion devices has reduced.

For Instance: According to the data published by American Medical Association it was estimated that there was 48% reduction in total surgical procedures performed in the U.S. due to the COVID-19 pandemic. However, after the pandemic restrictions normalized, the volume of surgical procedures returned to normal levels.

The recent outbreak of recent COVID-19 variants in the region further restricts the surgical procedures performed, increasing the burden of infected countries.However, the healthcare facilities are handling the situation and providing more innovative solutions for delivering healthcare.

Moreover, the healthcare system has again took running pace nowadays.The postponed surgical procedures that are now taking place, posing high demand of autotransfusion devices and has opened the opportunity to gain the market share with innovative products.

For Instance: According to American Association of Orthopaedic Surgeons and Agency for Healthcare Research and Quality (AHRQ), an estimated 700,000 knee replacement and around 450,000 hip replacement procedures are performed in U.S. each year. Besides, according to an article published by University of Alabama in 2021, it was reported that 320,000 coronary artery bypass grafting procedures were performed in U.S. in 2020. Thus, the overall COVID-19 impact on North America autotransfusion devices market is negative but the market is again gaining traction and expected to grow in coming years.

The European economy is severely affected due to the exponential growth of COVID-19 cases in the region.The countries such as Spain, Italy, Germany, France, and the UK are among the most affected European countries and number of deaths were also high.

Since, the beginning of the pandemic millions of patients worldwide have had their care delayed as hospitals canceled non-urgent operations, including some surgeries for people with heart and orthopaedic conditions.A very large number of operations were cancelled or postponed owing to disruption caused by COVID-19.

Governments had mitigated against this major burden on patients by developing recovery plans and implementing strategies to restore surgical activity safely.For Instance: According to British Journal of Surgery, an estimated 28,404,603 operations were cancelled or postponed during the peak 12?weeks of disruption due to COVID-19.

The overall 12-week cancellation rate accounted to be 72•3%.

The aging population and lifestyle changes are leading to a steady increase in the prevalence of chronic medical conditions.The rapidly growing middle-class population and urbanization are driving the adoption of sedentary lifestyle.

The World Health Organization (WHO) estimated a rise in the prevalence of chronic diseases by 57% in 2020.Modernization of facilities reduces physical activities among people and increases stress from personal, professional, and societal factors.

Arthritis, cardiovascular diseases, breast and colon cancer, diabetes, epilepsy and seizures, obesity, and oral health problems are the leading chronic diseases reported among elderlies in developed countries. Chronic diseases affect public health, societies, and economies.

According to the data published by the National Institute of Cancer Prevention and Research (NICPR) and the Indian Council of Medical Research (ICMR), the yearly prevalence of cancer in India is estimated at ~2.25 million, leading to numerous surgical procedures. Autotransfusion devices are widely used in various surgical procedures, such as cardiac surgery and other invasive procedures. Chronic diseases such as cancer, cardiovascular diseases, and renal disorders are major causes of human death worldwide. These conditions are generally treated via surgical procedures, which are associated with a chance of excessive blood loss. Fresh blood or their own blood is infused into patients to maintain the blood level. Autotransfusion devices are used during the blood infusion or reinfusion processes. Therefore, the global autotransfusion devices market is growing with the rapid increase in chronic diseases.

Companies such Zimmer Biomet, SARSTEDT AG and Co.KG and others have been implementing various inorganic developments that have bought about dynamic improvements in the autotransfusion devices market due to the involvement of major players which has led to availability of better products in the market.

Recently, in December 2020, Zimmer Biomet acquired A&E Medical Corporation for USD 150 million in cash at closing and USD 100 million in cash payable in 2021.As per the terms of the acquisition, Zimmer Biomet acquired A&E Medical and its complete portfolio of sternal closure devices – including sternal sutures, cable systems, and rigid fixation.

Similarly, in April 2020, SARSTEDT AG and Co.KG acquired 80% of the shares in Timedico A/S and secured a right to acquire additional 20% in the near future.

The acquisition has helped the company to leverage its value proposition to company’s global customers.

Type Insights
The autotransfusion devices market is segmented into type, application, and end user.Based on the type, the market is bifurcated into products and accessories.

The accessories segment held the largest share of the market in 2021, and similar segment is estimated to register the highest CAGR in the autotransfusion devices market during the forecast period.

The Food and Drug Administration, the Australian Blood Management, the Business Monitor International, the National Institute of Metrology Standardization and Industrial Quality, the National Blood Authority, the Northern Ireland Blood Transfusion Service, the National Institute of Cancer Prevention and Research, and the Organ Procurement and Transplantation Network are among the primary and secondary sources referred to while preparing the report on the autotransfusion devices market.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

ref:plp2022

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on